MEPCE
7SK snRNA methylphosphate capping enzyme
Also known as: BCDIN3, FLJ20257, MEPCE_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7L2J0
- Gene
- MEPCE
- Ensembl
- ENSG00000146834
- Chromosome
- 7
- Canonical length
- 689 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cell Junctions
OverviewNCBI Gene
Enables 7SK snRNA binding activity and RNA 5'-gamma-phosphate methyltransferase activity. Involved in RNA modification; positive regulation of protein localization to Cajal body; and positive regulation of snRNA transcription by RNA polymerase II. Located in nucleus. Part of 7SK snRNP. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
689 residues, UniProt reviewed canonical sequence.
>Q7L2J0|MEPCE
1 MIEMAAEKEP FLVPAPPPPL KDESGGGGGP TVPPHQEAAS GELRGGTERG PGRCAPSAGS
61 PAAAVGRESP GAAATSSSGP QAQQHRGGGP QAQSHGEARL SDPPGRAAPP DVGEERRGGG
121 GTELGPPAPP RPRNGYQPHR PPGGGGGKRR NSCNVGGGGG GFKHPAFKRR RRVNSDCDSV
181 LPSNFLLGGN IFDPLNLNSL LDEEVSRTLN AETPKSSPLP AKGRDPVEIL IPKDITDPLS
241 LNTCTDEGHV VLASPLKTGR KRHRHRGQHH QQQQAAGGSE SHPVPPTAPL TPLLHGEGAS
301 QQPRHRGQNR DAPQPYELNT AINCRDEVVS PLPSALQGPS GSLSAPPAAS VISAPPSSSS
361 RHRKRRRTSS KSEAGARGGG QGSKEKGRGS WGGRHHHHHP LPAAGFKKQQ RKFQYGNYCK
421 YYGYRNPSCE DGRLRVLKPE WFRGRDVLDL GCNVGHLTLS IACKWGPSRM VGLDIDSRLI
481 HSARQNIRHY LSEELRLPPQ TLEGDPGAEG EEGTTTVRKR SCFPASLTAS RGPIAAPQVP
541 LDGADTSVFP NNVVFVTGNY VLDRDDLVEA QTPEYDVVLC LSLTKWVHLN WGDEGLKRMF
601 RRIYRHLRPG GILVLEPQPW SSYGKRKTLT ETIYKNYYRI QLKPEQFSSY LTSPDVGFSS
661 YELVATPHNT SKGFQRPVYL FHKARSPSHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MEPCE can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 76 nTPM
Expression across tissuesHPA
Tissue
- testis: 76 nTPM
- spleen: 54 nTPM
- ovary: 40 nTPM
- adrenal gland: 40 nTPM
- skin: 40 nTPM
- parathyroid gland: 39 nTPM
Single-cell type
- platelets: 17 nCPM
- epididymal basal cells: 14 nCPM
- epididymal efferent duct ciliated cells: 11 nCPM
- ependymal cells: 9.9 nCPM
- renal connecting tubule cells: 8.4 nCPM
- epididymal clear cells: 8.2 nCPM
Immune cell
- total PBMC: 9.5 nTPM
- plasmacytoid DC: 8.3 nTPM
- naive B-cell: 8.2 nTPM
- memory B-cell: 8.1 nTPM
- naive CD4 T-cell: 8.1 nTPM
- naive CD8 T-cell: 7.3 nTPM
Brain region
- cerebral cortex: 37 nTPM
- basal ganglia: 36 nTPM
- thalamus: 36 nTPM
- white matter: 36 nTPM
- medulla oblongata: 35 nTPM
- amygdala: 34 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.21
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.99
- DepMap mean gene effect
- -1.06
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of transcription by RNA polymerase II
- positive regulation of G1/S transition of mitotic cell cycle
- positive regulation of protein localization to Cajal body
- positive regulation of snRNA transcription by RNA polymerase II
- RNA methylation
- snRNA metabolic process
- snRNA modification
Molecular functions
- 7SK snRNA binding
- O-methyltransferase activity
- RNA binding
- RNA methyltransferase activity
- S-adenosylmethionine-dependent methyltransferase activity
- snRNA binding
- RNA 5'-gamma-phosphate methyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MEPCE in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MEPCE as an antibody target. Whether an autoantibody or antibody against MEPCE could matter depends on whether native MEPCE is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MEPCE is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MEPCE as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...